New Risk • Jun 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Earnings have declined by 75% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change). New Risk • May 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Earnings have declined by 75% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change). Reported Earnings • Apr 28
Full year 2025 earnings released: CN¥1.28 loss per share (vs CN¥1.95 loss in FY 2024) Full year 2025 results: CN¥1.28 loss per share (improved from CN¥1.95 loss in FY 2024). Revenue: CN¥3.93b (down 3.7% from FY 2024). Net loss: CN¥154.9m (loss narrowed 34% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 125 percentage points per year, which is a significant difference in performance. Anuncio • Apr 28
Polyrocks Chemical Co.,LTD, Annual General Meeting, May 18, 2026 Polyrocks Chemical Co.,LTD, Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Qingyuan, Guangdong China Anuncio • Mar 30
Polyrocks Chemical Co.,LTD to Report Q1, 2026 Results on Apr 28, 2026 Polyrocks Chemical Co.,LTD announced that they will report Q1, 2026 results on Apr 28, 2026 Reported Earnings • Mar 05
Full year 2025 earnings released: CN¥0.98 loss per share (vs CN¥1.95 loss in FY 2024) Full year 2025 results: CN¥0.98 loss per share (improved from CN¥1.95 loss in FY 2024). Revenue: CN¥3.99b (down 2.1% from FY 2024). Net loss: CN¥118.6m (loss narrowed 50% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 119 percentage points per year, which is a significant difference in performance. Anuncio • Dec 26
Polyrocks Chemical Co.,LTD to Report Fiscal Year 2025 Results on Apr 09, 2026 Polyrocks Chemical Co.,LTD announced that they will report fiscal year 2025 results on Apr 09, 2026 Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.028 (vs CN¥0.10 loss in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.028 (up from CN¥0.10 loss in 3Q 2024). Revenue: CN¥986.6m (flat on 3Q 2024). Net income: CN¥2.89m (up CN¥13.9m from 3Q 2024). Profit margin: 0.3% (up from net loss in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 132 percentage points per year, which is a significant difference in performance. Anuncio • Sep 30
Polyrocks Chemical Co.,LTD to Report Q3, 2025 Results on Oct 29, 2025 Polyrocks Chemical Co.,LTD announced that they will report Q3, 2025 results on Oct 29, 2025 Reported Earnings • Aug 31
Second quarter 2025 earnings released: CN¥0.033 loss per share (vs CN¥0.058 profit in 2Q 2024) Second quarter 2025 results: CN¥0.033 loss per share (down from CN¥0.058 profit in 2Q 2024). Revenue: CN¥868.1m (down 13% from 2Q 2024). Net loss: CN¥5.49m (down 149% from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 133 percentage points per year, which is a significant difference in performance. New Risk • Aug 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Earnings have declined by 76% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.6% average weekly change). Anuncio • Jun 30
Polyrocks Chemical Co.,LTD to Report First Half, 2025 Results on Aug 26, 2025 Polyrocks Chemical Co.,LTD announced that they will report first half, 2025 results on Aug 26, 2025 New Risk • Jun 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 76% per year over the past 5 years. Reported Earnings • May 03
First quarter 2025 earnings released: EPS: CN¥0.07 (vs CN¥0.08 loss in 1Q 2024) First quarter 2025 results: EPS: CN¥0.07 (up from CN¥0.08 loss in 1Q 2024). Revenue: CN¥1.11b (down 7.4% from 1Q 2024). Net income: CN¥8.37m (up CN¥18.0m from 1Q 2024). Profit margin: 0.8% (up from net loss in 1Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 115 percentage points per year, which is a significant difference in performance. Anuncio • Apr 29
Polyrocks Chemical Co.,LTD, Annual General Meeting, May 19, 2025 Polyrocks Chemical Co.,LTD, Annual General Meeting, May 19, 2025, at 14:30 China Standard Time. New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.6% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 58% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.3% average weekly change). Anuncio • Mar 28
Polyrocks Chemical Co.,LTD to Report Q1, 2025 Results on Apr 29, 2025 Polyrocks Chemical Co.,LTD announced that they will report Q1, 2025 results on Apr 29, 2025 Reported Earnings • Mar 03
Full year 2024 earnings released: CN¥1.18 loss per share (vs CN¥0.24 profit in FY 2023) Full year 2024 results: CN¥1.18 loss per share (down from CN¥0.24 profit in FY 2023). Revenue: CN¥4.18b (up 13% from FY 2023). Net loss: CN¥143.5m (down CN¥172.0m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance. Anuncio • Dec 27
Polyrocks Chemical Co.,LTD to Report Fiscal Year 2024 Results on Apr 15, 2025 Polyrocks Chemical Co.,LTD announced that they will report fiscal year 2024 results on Apr 15, 2025 Reported Earnings • Oct 29
Third quarter 2024 earnings released: CN¥0.29 loss per share (vs CN¥0.10 profit in 3Q 2023) Third quarter 2024 results: CN¥0.29 loss per share (down from CN¥0.10 profit in 3Q 2023). Revenue: CN¥994.6m (down 14% from 3Q 2023). Net loss: CN¥11.0m (down 188% from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. Anuncio • Sep 30
Polyrocks Chemical Co.,LTD to Report Q3, 2024 Results on Oct 29, 2024 Polyrocks Chemical Co.,LTD announced that they will report Q3, 2024 results on Oct 29, 2024 New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Anuncio • Jun 29
Polyrocks Chemical Co.,LTD to Report First Half, 2024 Results on Aug 27, 2024 Polyrocks Chemical Co.,LTD announced that they will report first half, 2024 results on Aug 27, 2024 New Risk • May 11
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.2% Last year net profit margin: 1.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 332% Paying a dividend despite having no free cash flows. Earnings have declined by 43% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Anuncio • Apr 29
Polyrocks Chemical Co.,LTD, Annual General Meeting, May 17, 2024 Polyrocks Chemical Co.,LTD, Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Qingyuan, Guangdong China Reported Earnings • Apr 28
First quarter 2024 earnings released: CN¥0.08 loss per share (vs CN¥0.12 profit in 1Q 2023) First quarter 2024 results: CN¥0.08 loss per share (down from CN¥0.12 profit in 1Q 2023). Revenue: CN¥1.20b (up 44% from 1Q 2023). Net loss: CN¥9.68m (down 167% from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 49 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Apr 17
Now 30% overvalued Over the last 90 days, the stock has fallen 29% to CN¥12.11. The fair value is estimated to be CN¥9.34, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has declined by 66%. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥11.00, the stock trades at a trailing P/E ratio of 42.4x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 63% over the past three years. Anuncio • Mar 30
Polyrocks Chemical Co.,LTD to Report Q1, 2024 Results on Apr 27, 2024 Polyrocks Chemical Co.,LTD announced that they will report Q1, 2024 results on Apr 27, 2024 Reported Earnings • Feb 29
Full year 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.37 in FY 2022) Full year 2023 results: EPS: CN¥0.26 (down from CN¥0.37 in FY 2022). Revenue: CN¥3.74b (down 5.6% from FY 2022). Net income: CN¥31.5m (down 30% from FY 2022). Profit margin: 0.8% (down from 1.1% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 40 percentage points per year, which is a significant difference in performance. New Risk • Feb 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risks High level of debt (73% net debt to equity). Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Feb 06
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to CN¥11.50, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 24x in the Chemicals industry in China. Total loss to shareholders of 65% over the past three years. Valuation Update With 7 Day Price Move • Jan 23
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥15.29, the stock trades at a trailing P/E ratio of 37.1x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 55% over the past three years. New Risk • Nov 21
New major risk - Revenue and earnings growth Earnings have declined by 20% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risks High level of debt (73% net debt to equity). Large one-off items impacting financial results. Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.25 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥1.06b (down 10% from 2Q 2022). Net income: CN¥17.8m (down 57% from 2Q 2022). Profit margin: 1.7% (down from 3.5% in 2Q 2022). Anuncio • Jun 28
Polyrocks Chemical Co.,LTD to Report First Half, 2023 Results on Aug 29, 2023 Polyrocks Chemical Co.,LTD announced that they will report first half, 2023 results on Aug 29, 2023 Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to CN¥18.06, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 29% over the past year. Reported Earnings • Mar 02
Full year 2022 earnings released: EPS: CN¥0.49 (vs CN¥0.91 in FY 2021) Full year 2022 results: EPS: CN¥0.49 (down from CN¥0.91 in FY 2021). Revenue: CN¥4.33b (up 70% from FY 2021). Net income: CN¥45.5m (down 45% from FY 2021). Profit margin: 1.1% (down from 3.3% in FY 2021). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Feb 14
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥29.11, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 9.6% over the past year. Anuncio • Dec 10
Polyrocks Chemical Co.,LTD announced that it expects to receive CNY 299.999989 million in funding Polyrocks Chemical Co.,LTD announced a private placement to issue not more than 16,393,442 shares at an issue price of CNY 18.30 per share for an aggregate gross proceeds of not more than CNY 300,000,000 on December 8, 2022. The company announced a share subscription agreement with the investor. The transaction will include participation from returning investors, Chen Gang for 15,846,994 shares and Yang Zhenggao for 546,448 shares. Post completion of the transaction the stake of Chen Gang will increase from 4.99% to 18.69% and Yang Zhenggao will decrease from 3.54% to 3.51%. The shares to be issued shall have a hold period of 18 months from closing of the transaction. The transaction has been approved at the 9th meeting of the company’s 6th directorate and 7th meeting of the 6th supervisory board of the company. The transaction is still subject to approval from shareholders, Shanghai Stock Exchange, and the China Securities Regulatory Commission. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Oct 31
Third quarter 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.15 profit in 3Q 2021) Third quarter 2022 results: CN¥0.20 loss per share (down from CN¥0.15 profit in 3Q 2021). Revenue: CN¥1.10b (up 73% from 3Q 2021). Net loss: CN¥18.4m (down 233% from profit in 3Q 2021). Reported Earnings • Sep 02
Second quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.26 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.33 (up from CN¥0.26 in 2Q 2021). Revenue: CN¥1.18b (up 80% from 2Q 2021). Net income: CN¥41.3m (up 50% from 2Q 2021). Profit margin: 3.5% (down from 4.2% in 2Q 2021). Reported Earnings • May 02
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.27 (down from CN¥0.36 in 1Q 2021). Revenue: CN¥943.8m (up 65% from 1Q 2021). Net income: CN¥17.0m (down 36% from 1Q 2021). Profit margin: 1.8% (down from 4.6% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 37%. Reported Earnings • Feb 27
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥0.92 (down from CN¥2.27 in FY 2020). Revenue: CN¥2.76b (up 44% from FY 2020). Net income: CN¥84.5m (down 47% from FY 2020). Profit margin: 3.1% (down from 8.2% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 6.9%. Earnings per share (EPS) missed analyst estimates by 36%. Over the next year, revenue is forecast to grow 39%, compared to a 47% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Dec 30
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥45.12, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 21x in the Chemicals industry in China. Valuation Update With 7 Day Price Move • Dec 08
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥44.05, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.72 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥638.6m (up 20% from 3Q 2020). Net income: CN¥13.9m (down 72% from 3Q 2020). Profit margin: 2.2% (down from 9.5% in 3Q 2020). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Oct 13
Investor sentiment deteriorated over the past week After last week's 19% share price decline to CN¥34.86, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improved over the past week After last week's 27% share price gain to CN¥44.27, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 20x in the Chemicals industry in China. Reported Earnings • Aug 31
Second quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.72 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥654.1m (up 23% from 2Q 2020). Net income: CN¥27.6m (down 45% from 2Q 2020). Profit margin: 4.2% (down from 9.5% in 2Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.43 in 1Q 2020) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: CN¥570.9m (up 29% from 1Q 2020). Net income: CN¥26.3m (down 13% from 1Q 2020). Profit margin: 4.6% (down from 6.8% in 1Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Apr 03
Full year 2020 earnings released: EPS CN¥2.27 (vs CN¥1.44 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥1.92b (up 31% from FY 2019). Net income: CN¥158.8m (up 60% from FY 2019). Profit margin: 8.2% (up from 6.7% in FY 2019). The increase in margin was driven by higher revenue. Anuncio • Feb 17
Polyrocks Chemical Co., Ltd to Report Fiscal Year 2020 Results on Apr 26, 2021 Polyrocks Chemical Co., Ltd announced that they will report fiscal year 2020 results on Apr 26, 2021 Valuation Update With 7 Day Price Move • Feb 10
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥40.70, the stock is trading at a trailing P/E ratio of 17.5x, down from the previous P/E ratio of 20.8x. This compares to an average P/E of 35x in the Chemicals industry in China.